Key result
Atorvastatin significantly reduced blood levels of cholesterol, insulin, TNF-α, and insulin resistance index, and decreased hyperresponsiveness to phenylephrine and KCl in insulin-resistant rats.
Why the study?
Does atorvastatin improve aortic vascular reactivity and insulin resistance in high fructose-fed rats?
Does atorvastatin improve aortic vascular reactivity and insulin resistance in high fructose-fed rats?
Atorvastatin protects against aortic vascular reactivity impairment in insulin-resistant rats by reducing cholesterol and TNF-α levels.
Hypothesis-generating in insulin-resistant rats; leaves open any clinical translation to human vascular reactivity.
This study aimed to investigate the possible protective role of atorvastatin against the vascular dysfunction associated with insulin resistance (IR) in high fructose‐fed rats. In the pursuit of this aim, blood levels of glucose, cholesterol, insulin as well as vascular reactivity and insulin resistance index were assessed in a well‐established model of insulin resistance in presence or absence of atorvastatin (10 mg/kg/day for 8 weeks). Fructose feeding (10% fructose in drinking water for 8 weeks) induced hypercholesterolemia, hyperinsulinemia without any change in blood glucose level. Additionaly, serum tumor necrosis factor (TNF‐α), insulin resistance index, leukocyte infiltration of aorta and endothelial cell pyknosis were elevated. Fructose feeding induced hyperresponsiveness to both phenylephrine (PE) and KCl and hyporesponsiveness to ACh but not to sodium nitroprusside (SNP) relaxations. Most importantly, in atorvastatin‐treated rats, blood levels of cholesterol, insulin and TNF‐α, in addition to insulin resistance index were significantly reduced. Furthermore, atorvastatin treatment reduced leukocyte infiltration and endothelial cell pyknosis and decreased the hyperresponsiveness to both phenylephrine and KCl. In conclusion, the current study highlights a protective role for atorvastatin against the impairment in aortic vascular reactivity via a mechanism that involves reduction of the elevated cholesterol and TNF‐α levels in insulin resistance rats.
No takes yet. Share an insight, caveat, or question.
El‐Moselhy et al. (2011) studied Insulin resistance. Atorvastatin vs. Absence of atorvastatin was evaluated on Blood levels of glucose, cholesterol, insulin, vascular reactivity, and insulin resistance index. Atorvastatin significantly reduced blood levels of cholesterol, insulin, TNF-α, and insulin resistance index, and decreased hyperresponsiveness to phenylephrine and KCl in insulin-resistant rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: